Project Grant HT94252310977
Award Date
9/30/23
Completion Date
9/29/25
Dollars Obligated
$2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cary, NC 27518, USA
Similar Awards
The Defense Health Agency awarded Syracuse University a $1,099,513 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop antimicrobial shape memory polymer foams for rapid hemorrhage control and infection prevention in traumatic wounds. The grant period runs from August 15, 2023 to August 14, 2026. The research aims to transform health care for Service Members and the American public through innovative and impactful biomedical research focused on...
The U.S. Department of Defense (DoD) Defense Health Agency awarded a $1,820,004 Project Grant to Case Western Reserve University's Office of Research Administration Division, doing business as the University Hospitals of Cleveland, under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "HEMOSEAL: COMBINATORIAL NANOPARTICLE TECHNOLOGY FOR POINT-OF-INJURY HEMORRHAGE CONTROL," will support the development of an innovative nanoparticle-based technology...
The U.S. Department of Defense's Defense Health Agency has awarded a $902,109 Project Grant to North Carolina State University (NC State) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "HEMOSEAL: COMBINATORIAL NANOPARTICLE TECHNOLOGY FOR POINT-OF-INJURY HEMORRHAGE CONTROL," supports the development of advanced nanoparticle-based technologies to improve hemorrhage control at the point of injury. The award period runs from July 1, 2024 to...
The Department of the Army Medical Command awarded Cayuga Biotech Inc. a $922,870 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will support Cayuga Biotech's development of an intravenous agent for traumatic hemorrhage control from July 1, 2021 to June 30, 2022. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions, including investigations into...
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $4,000,000.00 in funding to Medcura, Inc. in Riverdale, MD to expand the development and production of a biopolymer powder treatment for noncompressible torso hemorrhage. The research aims to improve health outcomes for military service members and the broader public by advancing this innovative medical technology. The award period extends from Aug 5,...
The Department of the Army Medical Command awarded a $409,121 project grant to the Rochester Institute of Technology under the Military Medical Research and Development program (CFDA 12.420). The grant will fund the development of a novel 3D scleroderma skin model to test therapeutic modulation of TRPC6 from July 2022 through July 2025. Through this research, the awardee aims to advance the development of medical solutions for the battlefield by investigating potential treatments for...
This $1,993,215 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research focused on developing an RNA therapy to control thromboembolism (blood clots) after polytrauma. The prime awardee, Versiti Wisconsin, Inc., a non-profit blood center and research organization, is collaborating with the University of North Carolina at Chapel Hill and the Medical College of Wisconsin to...
The U.S. Defense Health Agency awarded a $1,213,276 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2023 through August 31, 2026, will fund research on the role of vascular mimicry in the outgrowth of dormant melanoma micrometastases. The goal of this research is to transform health care for Service Members and the American public through innovative and impactful medical research on solutions...
This Project Grant award of $829,406 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by the Texas A&M Engineering Experiment Station (Tees) on "Platelet Pathophysiology in Resistance to Antiangiogenic Therapy Against Ovarian Cancer Evaluated in a Vascularized TME-Chip". The 4-year project, running from August 2024 to July 2028, will investigate the role of platelets in the tumor microenvironment and resistance to...
The U.S. Department of Defense's Defense Health Agency (DHA) awarded a $750,000 Project Grant to Stanford University to implement a spatial and single-cell multiplexed platform for the development of targeted therapies for vascularized composite allotransplantation. The funding is provided through the Military Medical Research and Development (CFDA 12.420) federal grant program, which supports advanced biomedical research to transform healthcare for military service members and the broader...